Innovations to Simplify Interventions. As the interventional cornerstone of Teleflex, we offer a growing portfolio of specialty-focused solutions to support interventionalists around the globe. Our products are known for their innovative ability to simplify complex procedures and common clinical challenges.
November 15 – 19
New York, NY
A clinical investigation related to percutaneous coronary interventions is planned to be conducted under the exception from informed consent regulations in select cities. To learn more and provide feedback, please visit ringerinvestigation.com
USA: 800-447-IABP 24/7 (Current IABP Customers) International: 978-250-5177All other products: 888-413-3104
CAUTION: Federal (USA) law restricts this device to sale by or on the order of a physician. Not all products are available in all regions. Please contact customer service to confirm availability in your region.
The MANTA Vascular Closure Device is indicated for closure of femoral arterial access sites while reducing time to hemostasis following the use of 10-20F devices or sheaths (12-25F OD) in endovascular catheterization procedures.
There are no known contraindications to the use of this device.
The following potential adverse events related to the deployment of Vascular Closure Devices have been identified:
Teleflex, the Teleflex logo, Arrow, AC3 Optimus, Glider, GuideLiner, MANTA, OnControl, and TrapLiner
are trademarks or registered trademarks of Teleflex Incorporated or
MC-004110 Rev 0.1